跳至主要内容
临床试验/NCT01454687
NCT01454687撤回不适用

Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes

Stanford University0 个研究点开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Expression of the correct protein at the basement membrane zone

研究概览

简要总结

The term epidermolysis bullosa (EB) is used to describe a group of genetic skin diseases associated with skin weakness, blisters, and chronic wounds. "Revertant mosaicism" means that there are two genetically different populations of cells due to spontaneous mutations. Some EB patients have normal, non-fragile skin patches which may be areas of revertant mosaicism. In the revertant areas, the proteins function normally, like non-EB skin. In this study, we plan to culture cells from the revertant areas and graft them on to the wounded areas.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of EB (simplex, junctional or dystrophic)
  • Areas of revertant skin that has been confirmed by biopsy
  • 18 years or older subject willing and able to give consent
  • Confirmation of EB diagnosis by immunofluorescence (IF), electron microscopy (EM), and genetic testing confirming mutation
  • At least 100 to 200 cm2 of open erosions on the trunk and/or extremities suitable for skin grafting
  • Able to undergo adequate anesthesia to allow grafting procedures to take place

排除标准

  • Medical instability limiting ability to travel to Stanford University Medical Center
  • The presence of medical illness expected to complicate participation and/or compromise the safety of this technique
  • Active infection with HIV, hepatitis B, or hepatitis C
  • Active infection in the area that will undergo grafting
  • Evidence of a systemic infection
  • Current evidence or a history of skin cancer in the area that will undergo grafting
  • Active drug or alcohol addiction
  • Hypersensitivity to vancomycin or amikacin
  • Receipt of chemical or biological study product for the specific treatment ofEB in the past six months
  • Positive pregnancy test or breast-feeding

结局指标

主要结局

Expression of the correct protein at the basement membrane zone

时间窗: Week 52

Engraftment and healing of wounds with genetically revertant keratinocytes

时间窗: Week 52

次要结局

  • Engraftment and healing of wounds with genetically revertant keratinocytes(Week 25)
  • Expression of correct protein at the basement membrane zone(Week 8-12)
  • Expression of the correct protein at the basement membrane zone(Week 25)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alfred Lane

Professor, Departments of Dermatology and Pediatrics

Stanford University

相似试验